PUBLISHER: Grand View Research | PRODUCT CODE: 1301167
PUBLISHER: Grand View Research | PRODUCT CODE: 1301167
The global non-PVC IV bags market size is expected to reach USD 3.97 billion by 2030, exhibiting a CAGR of 11.3% from 2023 to 2030, according to a new report by Grand View Research, Inc. Demand for non-PVC substitutes is expected to grow in response to increasing global demand for nontoxic medical packaging and stringent legislation banning the use of polyvinyl chloride (PVC). Significant research and development for new alternatives is also expected to drive the global non-PVC IV bags market over the forecast period.
Non-PVC IV bags are majorly used for parenteral nutrition and chemotherapy. With the advent of different varieties of substitutes such as EVA and polypropylene, PVC packaging is likely to be replaced by non-PVC substitutions such as polypropylene and EVA. These materials might be utilized for several purposes, such as cold or frozen storage and custom mixtures. Thus, the wide applicability of non-PVC IV bags is expected to propel the non-PVC IV bags market growth over the forecast period.
In addition, stringent regulatory policies related to PVC IV bags have led to the increase in the use of non-PVC materials in the medical and non-medical industries. The global movement toward non-PVC materials provides tremendous growth prospects, drawing producers and investors to the sector. Non-PVC IV bags are becoming more common in parenteral nutrition services. Since the composition varies from patient to patient, they have a high demand for multi-chambered containers. With the introduction of tailored clinical solutions, the need for customized IV bag suppliers is expected to grow.